Silver Book Fact

Low dose CT screening for lung cancer costs less than $200 per person, and surgery for stage I lung cancer is less than 1/2 the cost of late-stage treatment.

International Early Lung Cancer Action Program Investigators. Survival of Patients with Stage I Lung Cancer Detected on CT Screening. NEJM. October 2006; 355(17): 1763-71. http://content.nejm.org/cgi/content/abstract/355/17/1763

Reference

Title
Survival of Patients with Stage I Lung Cancer Detected on CT Screening
Publication
NEJM
Publication Date
October 2006
Authors
International Early Lung Cancer Action Program Investigators
Volume & Issue
Volume 355, Issue 17
Pages
1763-71
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • Drugs like bevacizumab- designed to impede the growth of blood vessels and tumors- can cost more than $100,000 per patient.   
  • Widespread use of selective estrogen receptor modulators could result in an approximately 30% decrease in breast cancer.  
  • Improvements in surgical techniques and combination therapies increased the 1-year survival rate for lung cancer from 34 percent in 1975-1977 to 45 percent in 2006-2009.  
  • Widespread use of cancer vaccines could result in a cure of melanoma/renal cell carcinomas and a 25% boost in survival for all other cancers.  
  • Since Congress passed the National Cancer Act in 1971, the percentage of the U.S. population living with, through, or beyond a cancer diagnosis has more than tripled.